Experimental itch in sodium lauryl sulphate-inflamed and normal skin in humans: A randomized, double-blind, placebo-controlled study of histamine and other inducers of itch

British Journal of Dermatology

Volumn 146, Issue 5, 2002, Pages 792-800

  Thomsen, J S ^a   Sonne, M ^a   Benfeldt, E ^a   Jensen, S B ^b   Serup, J ^c   Menne, T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LEO PHARMA A S   (Denmark)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Histamine; Neuropeptides; Platelet activating factor; Pruritus; Serotonin; Trypsin

Indexed keywords

DODECYL SULFATE SODIUM; HISTAMINE; NEUROKININ A; NEUROKININ B; PLACEBO; SEROTONIN; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; TRYPSIN;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; NERVE CELL; NERVE FIBER C; PERFUSION; PRIORITY JOURNAL; PROVOCATION; PRURITUS; SCORING SYSTEM; SKIN INFLAMMATION; URTICARIA; VISUAL ANALOG SCALE;

EID: 0036108887     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04722.x     Document Type: Article

References (35)

1. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters
2. Influence of antihistamines, sedatives, and aspirin on experimental itch
3. Studies on experimental itch induced by kallikrein and bradykinin
4. Flare and itch induced by substance P in human skin
5. Correlations between histamine-induced wheal, flare and itch
6. Effects of menthol and cold on histamine-induced itch and skin reactions in man
7. Iontophoresis of histamine is a reliable model of experimental pruritus
8. Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls
9. Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch?
10. Topically applied aspirin rapidly decreases histamine-induced itch
11. Psychophysical studies of the itch sensation and itchy skin ('alloknesis') produced by intracutaneous injection of histamine
12. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects
13. Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction
14. Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis
15. Cutaneous reactions and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls
16. Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK-33-824, beta-endorphin and morphine
17. Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects
18. Pruritus in polycythemia vera: Treatment with aspirin and possibility of platelet involvement
19. Guidelines on sodium lauryl sulfate (SLS) exposure tests. A report from the Standardization Group of the European Society of Contact Dermatitis
20. Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis
21. Measurement of itch
22. High-potency topical corticosteroid rapidly decreases histamine-induced itch but not thermal sensation and pain in human beings
23. Influence of calcitonin gene-related peptide on histamine- and substance P-induced itch, flare and wheal in humans
24. Sensory neuropeptide effects in human skin
25. Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses
26. Vasoactive peptides in the skin
27. Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms
28. Multiple significance tests: The Bonferroni method
29. Itch: Role of prostaglandins
30. Histamine and cutaneous nociception: Histamine-induced responses in patients with atopic eczema, psoriasis and urticaria
31. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: In vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function
32. Histamine weal formation and absorption in man
33. The modulation of enhanced vascular permeability by prostaglandins through alterations in blood flow (hyperemia)
34. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability